Literature DB >> 31823110

Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease.

Sherry A Ferguson1, Vijayalakshmi Varma2, Daniel Sloper2, John J Panos3, Sumit Sarkar3.   

Abstract

Chronic neuroinflammation is strongly associated with AD and altered peripheral and central levels of chemokines and cytokines have been frequently described in those with AD. Given the increasing evidence of ethnicity-related differences in AD, it was of interest to determine if those altered chemokine and cytokine levels are ethnicity-related. Because African Americans exhibit a higher incidence of AD and increased symptom severity, we explored chemokine and cytokine concentrations in post-mortem brain tissue from the BA21 region of African Americans and Caucasians with AD using multiplex assays. IL-1β, MIG, TRAIL, and FADD levels were significantly increased in African Americans while levels of IL-3 and IL-8 were significantly decreased. Those effects did not interact with gender; however, overall levels of CCL25, CCL26 and CX3CL1 were significantly decreased in women. The NLRP3 inflammasome is thought to be critically involved in AD. Increased activation of this inflammasome in African Americans is consistent with the current results.

Entities:  

Keywords:  African American; Alzheimer’s disease; BA21; Chemokine; Cytokine; Ethnicity

Mesh:

Substances:

Year:  2019        PMID: 31823110     DOI: 10.1007/s11011-019-00512-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  136 in total

Review 1.  Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jorge A Fernández; Andrea A Maccioni; José M Jimenez; Ricardo B Maccioni
Journal:  Arch Med Res       Date:  2007-10-31       Impact factor: 2.235

2.  Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease.

Authors:  Sherry A Ferguson; John J Panos; Daniel Sloper; Vijayalakshmi Varma
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  CXCL8 protects human neurons from amyloid-β-induced neurotoxicity: relevance to Alzheimer's disease.

Authors:  Wei Kou; Robin Cotter; Kathleen Borgmann; Li Wu; Raisa Persidsky; Namita Sakhuja; Anuja Ghorpade
Journal:  Biochem Biophys Res Commun       Date:  2011-08-05       Impact factor: 3.575

4.  Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.

Authors:  Melissa Gartenberg Livney; Christopher M Clark; Jason H Karlawish; Su Cartmell; Mirna Negrón; Jessica Nuñez; Sharon X Xie; Fernando Entenza-Cabrera; Irving E Vega; Steven E Arnold
Journal:  Am J Geriatr Psychiatry       Date:  2011-05       Impact factor: 4.105

Review 5.  Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.

Authors:  Maria Serpente; Rossana Bonsi; Elio Scarpini; Daniela Galimberti
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

Review 6.  Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease.

Authors:  Christoffer Rosén; Henrik Zetterberg
Journal:  Curr Opin Psychiatry       Date:  2013-05       Impact factor: 4.741

7.  Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.

Authors:  Simantini Ghosh; Michael D Wu; Solomon S Shaftel; Stephanos Kyrkanides; Frank M LaFerla; John A Olschowka; M Kerry O'Banion
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

8.  Alzheimer's disease symptom severity in blacks and whites.

Authors:  M F Shadlen; E B Larson; L Gibbons; W C McCormick; L Teri
Journal:  J Am Geriatr Soc       Date:  1999-04       Impact factor: 5.562

9.  Sex differences in microglial CX3CR1 signalling determine obesity susceptibility in mice.

Authors:  Mauricio D Dorfman; Jordan E Krull; John D Douglass; Rachael Fasnacht; Fernando Lara-Lince; Thomas H Meek; Xiaogang Shi; Vincent Damian; Hong T Nguyen; Miles E Matsen; Gregory J Morton; Joshua P Thaler
Journal:  Nat Commun       Date:  2017-02-22       Impact factor: 14.919

10.  Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Front Cell Neurosci       Date:  2013-08-27       Impact factor: 5.505

View more
  5 in total

Review 1.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

2.  Elevated C-Reactive Protein in Alzheimer's Disease Without Depression in Older Adults: Findings From the Health and Retirement Study.

Authors:  Ginny Natale; Sean A P Clouston; Dylan M Smith
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

3.  Exposing the Brain Proteomic Signatures of Alzheimer's Disease in Diverse Racial Groups: Leveraging Multiple Data Sets and Machine Learning.

Authors:  Heather Desaire; Kaitlyn E Stepler; Renã A S Robinson
Journal:  J Proteome Res       Date:  2022-03-11       Impact factor: 5.370

4.  A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies.

Authors:  Yujian Xu; Youbai Chen; Zehao Niu; Jiahua Xing; Zheng Yang; Xiangye Yin; Lingli Guo; Qixu Zhang; Haixia Qiu; Yan Han
Journal:  Front Med (Lausanne)       Date:  2022-04-15

5.  System level modeling and analysis of TNF-α mediated sphingolipid signaling pathway in neurological disorders for the prediction of therapeutic targets.

Authors:  Sanam Banaras; Rehan Zafar Paracha; Maryum Nisar; Ayesha Arif; Jamil Ahmad; Muhammad Tariq Saeed; Zartasha Mustansar; Malik Nawaz Shuja; Rizwan Nasir Paracha
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.